Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Gross Profit: 2013-2024

Historic Gross Profit for ProQR Therapeutics N.V (PRQR) over the last 12 years, with Dec 2024 value amounting to $20.2 million.

  • ProQR Therapeutics N.V's Gross Profit fell 20.17% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year decrease of 12.03%. This contributed to the annual value of $20.2 million for FY2024, which is 186.70% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Gross Profit of $20.2 million as of FY2024, which was up 186.70% from $7.0 million recorded in FY2023.
  • ProQR Therapeutics N.V's Gross Profit's 5-year high stood at $20.2 million during FY2024, with a 5-year trough of $1.6 million in FY2021.
  • In the last 3 years, ProQR Therapeutics N.V's Gross Profit had a median value of $7.0 million in 2023 and averaged $10.3 million.
  • Per our database at Business Quant, ProQR Therapeutics N.V's Gross Profit skyrocketed by 610.58% in 2020 and then slumped by 74.49% in 2021.
  • ProQR Therapeutics N.V's Gross Profit (Yearly) stood at $6.2 million in 2020, then plummeted by 74.49% to $1.6 million in 2021, then surged by 132.10% to $3.7 million in 2022, then surged by 92.17% to $7.0 million in 2023, then spiked by 186.70% to $20.2 million in 2024.